EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access · CC BY 4.0

High-Flow Nasal Oxygen versus Noninvasive Ventilation in Acute Exacerbation of Chronic Obstructive Pulmonary Disease Patients: A Meta-Analysis of Randomized Controlled Trials

Yanping Du iD, Huaping Zhang iD, Zhiyi Ma iD, Jun Liu iD, Zhiyong Wang iD, Meixia Lin iD, Fayu Ni iD, Xi Li iD, Hui Tan iD, Shifan Tan iD, Yanling Chai iD, Xiangzhu Zhong iD

Canadian Respiratory Journal · 2023

DOI: 10.1155/2023/7707010 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Canadian Respiratory Journal, 2023. Verfasst von Yanping Du und 11 weiteren Autor:innen. Beteiligte Einrichtung: The School of Clinical Medicine, Fujian Medical University, Zhongshan Hospital Xiamen University, Fujian, China. Hauptthemen laut MEDLINE: Noninvasive Ventilation, Respiratory Insufficiency, Pulmonary Disease, Chronic Obstructive. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

High-flow nasal cannula (HFNC) can be used in stable chronic obstructive pulmonary disease (COPD) patients, but the effect of HFNC on clinical outcomes in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is still uncertain.

Methods

We searched electronic literature databases for randomized controlled trials (RCTs) comparing HFNC with noninvasive ventilation (NIV) in hypercapnic patients with AECOPD. The primary endpoint of this meta-analysis was PaCO2, PaO2, and SpO2. The secondary outcomes were the respiratory rate, mortality, complications, and intubation rate.

Results

We included 7 RCTs with a total of 481 patients. There were no significant differences on measures of PaCO2 (MD = −0.42, 95%CI −3.60 to 2.75, Z = 0.26, and P = 0.79), PaO2 (MD = −1.36, 95%CI −4.69 to 1.97, Z = 0.80, and P = 0.42), and SpO2 (MD = −0.78, 95%CI −1.67 to 0.11, Z = 1.72, P = 0.08) between the HFNC group and the NIV group. There was no significant difference in measures of the mortality and intubation rate between the HFNC group (OR = 0.72, 95%CI 0.30 to 1.69, Z = 0.76, and P = 0.44) and the NIV group (OR = 2.38, 95%CI 0.49 to 11.50, Z = 1.08, and P = 0.28), respectively. But the respiratory rate in the HFNC group was lower than that in the NIV group (MD = −1.13, 95%CI −2.13 to −0.14, Z = 2.23, and P = 0.03), and fewer complications were found in the HFNC group (OR = 0.26, 95%CI 0.14 to 0.47, Z = 4.46, and P < 0.00001).

Conclusion

NIV was noninferior to HFNC in decreasing PaCO2 and increasing PaO2 and SpO2. Similarly, the mortality and intubation rate was similar among the two groups. The respiratory rate and complications were inferior in the AECOPD group treated with HFNC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Noninvasive VentilationRespiratory InsufficiencyPulmonary Disease, Chronic ObstructiveHumansOxygenRandomized Controlled Trials as TopicOxygen Inhalation Therapy

Substanzen

Oxygen

Autor:innen und Institutionen

  • The School of Clinical Medicine, Fujian Medical University, Zhongshan Hospital Xiamen University, Fujian, China.
  • Pulmonary and Critical Care Medicine, Second Affiliated Hospital of Fujian Medical University, Respiratory Medicine Center of Fujian Province, Fujian, China.
  • Pulmonary and Critical Care Medicine, The First Hospital of Longyan Affiliated to Fujian Medical University, The School of Clinical Medicine, Fujian Medical University, Fujian, China.
  • Pulmonary and Critical Care Medicine, The School of Clinical Medicine, Fujian Medical University, The Second Hospital of Longyan, Fujian, China.
  • Pulmonary and Critical Care Medicine, The School of Clinical Medicine, Fujian Medical University, The First Hospital of Putian, Fujian, China.
  • Pulmonary and Critical Care Medicine, Fuqing Hospital Affiliated to Fujian Medical University, Fujian, China.

ORCID-Profile: Yanping Du, Huaping Zhang, Zhiyi Ma, Jun Liu, Zhiyong Wang, Meixia Lin, Fayu Ni, Xi Li, Hui Tan, Shifan Tan, Yanling Chai, Xiangzhu Zhong

Zitieren

APA

Du, Y., Zhang, H., Ma, Z., Liu, J., Wang, Z., Lin, M., Ni, F., Li, X., Tan, H., Tan, S., Chai, Y., & Zhong, X. (2023). High-Flow Nasal Oxygen versus Noninvasive Ventilation in Acute Exacerbation of Chronic Obstructive Pulmonary Disease Patients: A Meta-Analysis of Randomized Controlled Trials. Canadian Respiratory Journal. https://doi.org/10.1155/2023/7707010

Vancouver

Du Y, Zhang H, Ma Z, Liu J, Wang Z, Lin M, et al. High-Flow Nasal Oxygen versus Noninvasive Ventilation in Acute Exacerbation of Chronic Obstructive Pulmonary Disease Patients: A Meta-Analysis of Randomized Controlled Trials. Canadian Respiratory Journal. 2023. doi:10.1155/2023/7707010

BibTeX
@article{Du2023,
  author = {Du, Yanping and Zhang, Huaping and Ma, Zhiyi and Liu, Jun and Wang, Zhiyong and Lin, Meixia and Ni, Fayu and Li, Xi and Tan, Hui and Tan, Shifan and Chai, Yanling and Zhong, Xiangzhu},
  title = {High-Flow Nasal Oxygen versus Noninvasive Ventilation in Acute Exacerbation of Chronic Obstructive Pulmonary Disease Patients: A Meta-Analysis of Randomized Controlled Trials},
  journal = {Canadian Respiratory Journal},
  year = {2023},
  doi = {10.1155/2023/7707010}
}
Kostenlos starten →